Staphylococcus aureus resistance to antibiotics: Key points in 2010;Résistance aux antibiotiques chez Staphylococcus aureus: les points-clés en 2010

Medecine/Sciences

Volumn 26, Issue 11, 2010, Pages 943-949

  Dumitrescu, Oana ^a,b   Dauwalder, Olivier ^a,b   Boisset, Sandrine ^a,b   Reverdy, Marie Elisabeth ^a,b   Tristan, Anne ^a,b   Vandenesch, François ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 78650070611     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20102611943     Document Type: Review

References (33)

1. Oliveira DC, Tomasz A, Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002 ; 2:180-9.
2. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001 ; 357:1225-40.
3. Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillinresistant Staphylococcus aureus as a community pathogen. Diagn Microbiol lnfect Dis 2001; 40:1-4.
4. Ito T, Okuma K, Ma XX, et al. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003 ; 6:41-52.
5. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001 ; 9:486-93.
6. Katayama y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000 ; 44:1549-55.
7. Ito T, Ma XX, Takeuchi F, et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004 ; 48:2637-51.
8. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002 ; 46:2155-61.
9. International working group on the classification of staphylococcal cassette chromosome elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCOnec): guidelines far reporting navel SCCmec elements. Antimicrob Agents Chemother 2009 ; 53:4961-7.
10. Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin- resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009;53:531-40.
11. Hiramatsu K, Katayama Y, yuzawa H, et al. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol 2002 ; 292:67-74.
12. Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J Bacteriol 2003 ; 185:2711-22.
13. Tsubakishita S, Kuwahara-Arai K, Baba T, et al. Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus. Antimicrob Agents Chemother 2010 ; 54:1469-75.
14. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentme leukocidin. Clin Infect Dis 2002 ; 35:819-24.
15. Woodin AM. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 1960 ; 75:158-65.
16. Konig B, Prevost G, Piemont y, et al. Effects of Staphylococcus aureus leukocidins an inflammatory mediator release from human granulocytes. J Infect Dis 1995; 171: 607-13.
17. Gillet y, lssartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753-9.
18. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003 ; 9:978-84.
19. Dauwalder O, Una G, Durand G, et al. Epidemiology of invasive methicillinresistant Staphylococcus aureus clones collected in France in 2006 and 2007.; Clin Microbiol 2008 ; 46: 3454-8.
20. Durand G, Bes M, Meugnier H, et al. Detection of new methicillin- resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 2006 ; 44: 847-53.
21. Hiramatsu K, Antaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997 ; 350:1670-3.
22. Sancak B, Eras S, Menemenlioglu D, et al. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005 ; 56: 519-23.
23. Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.; Antimicrob Chemother 2001 ; 47:399-403.
24. Cui L, Iwamoto A, Lian JQ, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006 ; 50:428-38.
25. Swenson JM, Anderson KF, Lonsway DR, et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediote Staphylococcus aureus. J Clin Microbiol 2009;47:2013-7.
26. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.; Antimicrob Chemother 2007 ; 60: 788-94.
27. Ho PL, Lo PY, Chow KH, et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.; Infect 2010 ; 60:140-5.
28. Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008; 31 (suppl 2) : 1-9.
29. Sakoulas G, Moise-Broder PA, SchentagJ, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004 ; 42: 2398-402.
30. Maclayton DO, Suda KJ, Coval KA, et al. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 2006 ; 28:1208-16.
31. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008 ; 46:193-200.
32. Vandenesh F, Lina G, Gillet y et al. Chronique d'une controverse sur une bactérie équipée pour tuer. Med Sei (Paris) 2009 ; 25: 984-6.
33. Cattoir V, Leclercq R. Les entérocoques résistants aux glycopeptides. Med Sci (Paris) 2010; 26: 936-42.